Pamplona, Spain

Julen Oyarzabal Santamarina

USPTO Granted Patents = 7 

 

Average Co-Inventor Count = 5.2

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2016-2023

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Innovations of Julen Oyarzabal Santamarina

Introduction

Julen Oyarzabal Santamarina is a notable inventor based in Pamplona, Spain. He has made significant contributions to the field of medical research, particularly in the development of peptides that have potential applications in cancer treatment. With a total of seven patents to his name, his work is recognized for its innovative approach to addressing complex medical challenges.

Latest Patents

One of his latest patents is focused on FOXP3-binding peptides and their uses. The invention provides peptides of a specific general formula, which are designed to bind and inhibit FoxP3. These peptides are highly efficient in blocking Treg cell functionality, making them valuable in cancer treatment. The patent also includes constructs that comprise the peptide, as well as combinations that enhance its therapeutic potential.

Career Highlights

Throughout his career, Julen has worked with esteemed organizations such as Fundación para la Investigación Médica Aplicada and Fundación La Investigación Médica Aplicada. His work in these institutions has allowed him to advance his research and contribute to significant medical innovations.

Collaborations

Julen has collaborated with several professionals in his field, including Maria Obdulia Rabal Gracia and María Del Mar Cuadrado Tejedor. These collaborations have enriched his research and expanded the impact of his inventions.

Conclusion

Julen Oyarzabal Santamarina is a prominent inventor whose work in peptide research holds promise for cancer treatment. His innovative patents and collaborations reflect his commitment to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…